HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)

A heterogeneous group of primarily familial EPILEPSY disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis (see MUCOLIPIDOSES), and UNVERRICHT-LUNDBORG SYNDROME.
Also Known As:
Progressive Myoclonic Epilepsy; Epilepsy, Progressive Myoclonic; Dentatorubral-Pallidoluysian Atrophy; Myoclonic Epilepsies, Progressive; Ataxia, Chorea, Seizures, And Dementia; Atypical Inclusion-Body Disease; Familial Progressive Myoclonic Epilepsy; Haw River Syndrome; Myoclonic Epilepsy, Progressive; Myoclonus-Nephropathy Syndrome; Naito Oyanagi Disease; Naito-Oyanagi Disease; Progressive Myoclonus Epilepsies; Action Myoclonus Renal Failure Syndrome; Atrophies, Dentatorubral-Pallidoluysian; Atrophy, Dentatorubral-Pallidoluysian; Atypical Inclusion Body Disease; Atypical Inclusion-Body Diseases; Biotin Responsive Encephalopathy; Biotin-Responsive Encephalopathies; Dentatorubral Pallidoluysian Atrophy; Dentatorubral-Pallidoluysian Atrophies; Encephalopathies, Biotin-Responsive; Encephalopathy, Biotin-Responsive; Epilepsies, Progressive Myoclonic; Epilepsies, Progressive Myoclonus; Epilepsy, Progressive Myoclonus; Haw River Syndromes; Inclusion-Body Disease, Atypical; Inclusion-Body Diseases, Atypical; May White Syndrome; Myoclonus Epilepsies, Progressive; Myoclonus Nephropathy Syndrome; Myoclonus-Nephropathy Syndromes; Naito-Oyanagi Diseases; Progressive Myoclonus Epilepsy; River Syndromes, Haw; Syndromes, Myoclonus-Nephropathy; Action Myoclonus-Renal Failure Syndrome; Biotin-Responsive Encephalopathy; May-White Syndrome
Networked: 434 relevant articles (13 outcomes, 31 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Seizures (Absence Seizure)
2. Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
3. Myoclonus (Nocturnal Myoclonus)
4. Lafora Disease
5. Gaucher Disease (Gaucher's Disease)

Experts

1. Lehesjoki, Anna-Elina: 17 articles (01/2021 - 01/2002)
2. Sanz, Pascual: 9 articles (05/2021 - 12/2003)
3. Minassian, Berge A: 8 articles (10/2019 - 01/2002)
4. Tsuji, S: 8 articles (12/2004 - 01/2000)
5. Yamada, M: 8 articles (12/2004 - 05/2000)
6. Joensuu, Tarja: 7 articles (01/2021 - 02/2007)
7. Tsuji, Shoji: 7 articles (08/2011 - 05/2002)
8. Canafoglia, Laura: 6 articles (01/2021 - 05/2006)
9. Michelucci, Roberto: 6 articles (01/2021 - 01/2011)
10. Kopra, Outi: 6 articles (12/2015 - 05/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Progressive Myoclonic Epilepsies:
1. perampanelIBA
2. Zonisamide (Zonegran)FDA LinkGeneric
3. Cystatin BIBA
4. Serotonin (5 Hydroxytryptamine)IBA
5. Levetiracetam (Keppra)FDA LinkGeneric
6. Anticonvulsants (Antiepileptic Drugs)IBA
7. Topiramate (Topamax)FDA LinkGeneric
8. Serotonin AgentsIBA
9. Chloral HydrateIBA
10. Olanzapine (Zyprexa)FDA Link

Therapies and Procedures

1. Therapeutics
2. High-Protein Low-Carbohydrate Diet (Atkins Diet)
3. Activities of Daily Living (ADL)
4. Transcranial Magnetic Stimulation
5. Deep Brain Stimulation